Aug 14, 2025. Our paper on Armata Pharmaceuticals’ Phage Pa223 used in clinical trials NCT04596319 and NCT05616221 is out in the Journal of Molecular Biology!

Congratulations, Cingolani and Armata team, on this achievement. Pa223 is our second collaborative paper. Pa223 is a biomedicine to eradicate Pseudomonas aeruginosa.